Cargando…
Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247214/ https://www.ncbi.nlm.nih.gov/pubmed/37292116 http://dx.doi.org/10.1097/HS9.0000000000000905 |
| _version_ | 1785055149550469120 |
|---|---|
| author | Narita, Kentaro Ikeda, Daisuke Seki, Mizuki Fukumoto, Ami Tabata, Rikako Uesugi, Yuka Miura, Daisuke Takeuchi, Masami Doi, Masahiro Umezawa, Yuka Otsuka, Yoshihito Matsue, Kosei |
| author_facet | Narita, Kentaro Ikeda, Daisuke Seki, Mizuki Fukumoto, Ami Tabata, Rikako Uesugi, Yuka Miura, Daisuke Takeuchi, Masami Doi, Masahiro Umezawa, Yuka Otsuka, Yoshihito Matsue, Kosei |
| author_sort | Narita, Kentaro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10247214 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102472142023-06-08 Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study Narita, Kentaro Ikeda, Daisuke Seki, Mizuki Fukumoto, Ami Tabata, Rikako Uesugi, Yuka Miura, Daisuke Takeuchi, Masami Doi, Masahiro Umezawa, Yuka Otsuka, Yoshihito Matsue, Kosei Hemasphere Letter Lippincott Williams & Wilkins 2023-06-06 /pmc/articles/PMC10247214/ /pubmed/37292116 http://dx.doi.org/10.1097/HS9.0000000000000905 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Letter Narita, Kentaro Ikeda, Daisuke Seki, Mizuki Fukumoto, Ami Tabata, Rikako Uesugi, Yuka Miura, Daisuke Takeuchi, Masami Doi, Masahiro Umezawa, Yuka Otsuka, Yoshihito Matsue, Kosei Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study |
| title | Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study |
| title_full | Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study |
| title_fullStr | Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study |
| title_full_unstemmed | Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study |
| title_short | Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study |
| title_sort | prevalence and clinical outcome of omicron breakthrough infection in patients with hematologic disease: a prospective observational cohort study |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247214/ https://www.ncbi.nlm.nih.gov/pubmed/37292116 http://dx.doi.org/10.1097/HS9.0000000000000905 |
| work_keys_str_mv | AT naritakentaro prevalenceandclinicaloutcomeofomicronbreakthroughinfectioninpatientswithhematologicdiseaseaprospectiveobservationalcohortstudy AT ikedadaisuke prevalenceandclinicaloutcomeofomicronbreakthroughinfectioninpatientswithhematologicdiseaseaprospectiveobservationalcohortstudy AT sekimizuki prevalenceandclinicaloutcomeofomicronbreakthroughinfectioninpatientswithhematologicdiseaseaprospectiveobservationalcohortstudy AT fukumotoami prevalenceandclinicaloutcomeofomicronbreakthroughinfectioninpatientswithhematologicdiseaseaprospectiveobservationalcohortstudy AT tabatarikako prevalenceandclinicaloutcomeofomicronbreakthroughinfectioninpatientswithhematologicdiseaseaprospectiveobservationalcohortstudy AT uesugiyuka prevalenceandclinicaloutcomeofomicronbreakthroughinfectioninpatientswithhematologicdiseaseaprospectiveobservationalcohortstudy AT miuradaisuke prevalenceandclinicaloutcomeofomicronbreakthroughinfectioninpatientswithhematologicdiseaseaprospectiveobservationalcohortstudy AT takeuchimasami prevalenceandclinicaloutcomeofomicronbreakthroughinfectioninpatientswithhematologicdiseaseaprospectiveobservationalcohortstudy AT doimasahiro prevalenceandclinicaloutcomeofomicronbreakthroughinfectioninpatientswithhematologicdiseaseaprospectiveobservationalcohortstudy AT umezawayuka prevalenceandclinicaloutcomeofomicronbreakthroughinfectioninpatientswithhematologicdiseaseaprospectiveobservationalcohortstudy AT otsukayoshihito prevalenceandclinicaloutcomeofomicronbreakthroughinfectioninpatientswithhematologicdiseaseaprospectiveobservationalcohortstudy AT matsuekosei prevalenceandclinicaloutcomeofomicronbreakthroughinfectioninpatientswithhematologicdiseaseaprospectiveobservationalcohortstudy |